Turning out to be a good year for biotech. Let's hope it continues.
Have to admit that my stance on Her-vaxx safety has dropped. I've gone from thinking that safety was pretty much a given to thinking that the numbers are too small to be confident.
I'm very keen to see what comes up in the long term monitoring of these patients, what happens once the chemo is done and the immune system recovers? Does the chemo mask any Her-vaxx side-effects so that they only show up once chemo is finished and flushed? A lot of questions sitting under the safety and efficacy umbrellas.
cheers
Add to My Watchlist
What is My Watchlist?
